Taysha Gene Therapies, Inc. (TSHA) Q1 2022 Earnings Call Transcript

·44 min read
Taysha Gene Therapies, Inc. (TSHA) Q1 2022 Earnings Call Transcript

Joining me on today's call are RA Session II, Taysha's president, founder, and CEO; Dr. Suyash Prasad, chief medical officer and head of R&D and Kamran Alam, chief financial officer. After formal remarks, we will conduct a question-and-answer session, and instructions will follow at that time.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting